Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 1 Trials for DB11870 (RG-4733)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01158274RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsTreatment